PMcardio is an AI-powered platform designed to enhance cardiovascular diagnostics through cutting-edge ECG interpretation. It provides rapid and accurate analyses of heart conditions using advanced algorithms that identify issues such as reduced left ventricular ejection fraction, acute ST-elevation myocardial infarction (STEMI), and STEMI-equivalent patterns. PMcardio's technology facilitates earlier diagnosis and immediate referrals to specialists, optimizing patient care. Compatible with any 12-lead ECG, the platform streamlines cardiac assessments and reduces time for clinical decisions. Its widespread implementation across hospitals showcases its role in advancing cardiac care, aiding in cost reduction by minimizing the need for hospitalizations and complex interventions. Although CE-marked for use in Europe and the UK, it awaits FDA clearance for the US market. The tool stands out for its ability to democratize advanced cardiac diagnostic capabilities, ensuring broader accessibility and application in healthcare settings.